Yingshi Zhang

Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells

Yingshi Zhang, Dandan Li, Qiyu Jiang et al. · Cell Death and Disease · 2018 · 104 citations · Full text

Medicine, Oncology, Pharmacology +13

ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR

Zhi‐Yi Shao, Yibo Li, Wenjie Dai et al. · Pharmacological Research · 2018 · 85 citations

Medicine, Molecular Biology, Oncology +11

Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells <i>via</i> the miR-148a/PXR axis

Boan Li, Fan Feng, Hui Jia et al. · Food & Function · 2021 · 79 citations

Medicine, Oncology, Pharmacology +17

Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo

Hongyuan Lu, Yuxin Zu, Xiaowen Jiang et al. · Pharmacological Research · 2019 · 69 citations

Medicine, Oncology, Pharmacology +16

High efficiency solar interfacial evaporator for seawater desalination based on high porosity loofah sponge biochar

Qi Zhang, Qing Ye, Yingshi Zhang et al. · Solar Energy · 2022 · 59 citations

Engineering, Environmental Engineering, Water Resources Management +13